IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Aqualis acquires Norwegian API producer Weifa

6:43 AM MDT | June 17, 2014 | Deepti Ramesh

Aqualis (Oslo) announced on 17 June that it has entered into a definitive share purchase agreement with Weifa Holding to acquire all of the shares in Weifa (Oslo), a leading, fully-integrated pharmaceutical company in Norway and a major supplier of active pharmaceutical ingredients (APIs) to the international pharmaceutical industry, for 1.1 billion Norwegian kroner ($184 million). Aqualis is involved in the marine and offshore and health-care businesses. Weifa is a market leader within the consumer health pain-relief segment and a leading supplier of APIs for...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa